Self-Interest versus Group-Interest in Antiviral Control

Michiel van Boven, Don Klinkenberg, Ido Pen et al. · 2008

Read Self-Interest versus Group-Interest in Antiviral Control by Michiel van Boven, Don Klinkenberg, Ido Pen et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001558.txt.

Description

Michiel van Boven and co-authors published a 2008 PLOS ONE study on when people will take flu drugs. Drugs that curb viruses hold promise for new ills such as bird flu and SARS. But the drugs are not free of harm, so people weigh gain against risk. The team modeled when self interest and group gain pull in unlike ways.

In their model, what pays for one person can fail the group as a whole. That gap can stall a drug drive that needs wide uptake to work. Plans must thus align the two, with clear rules and fair access. The work frames a social snag that pure drug science cannot solve.

Catalog record

CREATORMichiel van Boven, Don Klinkenberg, Ido Pen et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001558

Browse the full library · About the Tower of Babel